<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>GBI - China pharma, biotech, and health news</title><link>http://www.gbipharma.com</link><description /><language>en-us</language><copyright>Copyright 2007 Generalbiologic</copyright><lastBuildDate>Mon, 09 Nov 2009 09:04:43  +0800</lastBuildDate><image><link>http://www.gbipharma.com/</link><url>http://www.gbipharma.com/google-pic.jpg</url><title>GBI - China pharma, biotech, and health news</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/cpbheadline" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item><title>China domestic pharma gross output to reach RMB 1 trillion, APIs slump</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Gross output for China's pharmaceutical industry may reach RMB 1 trill......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 06 Nov 2009 17:11:04  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Hole in one for Hutchison Medipharma ulcerative colitis trial</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Hutchison MediPharma, a subsidiary of Hutchison China Meditech, recent......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 06 Nov 2009 16:03:28  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Microbix plans macro-size flu vaccine facility in Hunan  --Free access</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/BiMUKOlhZ9I/cpbheadlinefree.asp</link><description>Canada-based Microbix Biosystems (TSE:MBX) signed an equal partnership......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/BiMUKOlhZ9I" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 06 Nov 2009 14:57:53  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbheadlinefree.asp?newsid=2010748</feedburner:origLink></item><item><title>Jilin pharmaceutical seeks better future with capacity expansion</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Jilin Pharmaceutical announced November 5 that the company plans to re......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 06 Nov 2009 11:13:44  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Shanghai Pharmaceutical receives shareholder approval for merger</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>The shareholders of Shanghai Pharmaceutical (SHA: 600849), Shanghai In......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 06 Nov 2009 11:13:05  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Hebei pharm companies experience drop in API production and export</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Pharmaceutical companies in Hebei witnessed a drop in production in 20......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 05 Nov 2009 14:22:39  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>MOH signs cooperation agreement with Novartis on community health</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Li Yin, vice Minister of Health, met with Daniel Vasella, president of......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 05 Nov 2009 13:30:33  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Chain of drugstores, shackles of debt- yours for 1 RMB</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Sanjiu Medical  and  Pharmaceutical (SHE:000999) and Shenzhen Sanjiu Medic......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 05 Nov 2009 13:28:57  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Shanghai Huashi Pharmacy to provide Tamiflu in 300 retail pharmacies</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Shanghai Huashi Pharmacy, a subsidiary of Shanghai Pharmaceutical (SHA......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 05 Nov 2009 13:27:24  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Intracranial aneurysms have detection rate of only 9%</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>The 9th Oriental Cerebrovascular Intervention Therapy Conference annou......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 16:50:37  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Biostar looking for big numbers from small outlets</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Biostar Pharmaceuticals (OTC: BSPM) announced November 3 that as of Se......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 16:21:47  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Exchanging exchanges: Sinovac hops from Amex to NASDAQ</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Sinovac Biotech (NYSE Amex: SVA) announced November 3 that is will tra......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 15:35:30  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Nepstar now offering drugs and money</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>China Nepstar Chain Drugstore (NYSE: NPD) has entered into an agreemen......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 15:27:34  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Novo Nordisk to double down on China, expand workforce</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Lars Rebien Sorensen, President and CEO of Novo Nordisk, announced tha......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 13:55:58  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Novartis continues China spending spree- acquires 85% of Tianyuan Bio-Pharma  --Free access</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/sIfRzymXTFY/cpbheadlinefree.asp</link><description>Novartis (NYSE:NVS) announced that it has signed a contract with Zheji......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/sIfRzymXTFY" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 13:54:38  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbheadlinefree.asp?newsid=2010734</feedburner:origLink></item><item><title>Novartis opens USD 250m API production/R&amp;D subsidiary in Suzhou</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Novartis (NYSE:NVS) announced November 2 that its subsidiary, Suzhou N......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 04 Nov 2009 13:53:15  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Shandong Province drug procurement black list to penalize non-standard practices</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Shandong Province announced recently that it will be keeping a record ......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 03 Nov 2009 16:39:22  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Beijing tier 2 hospitals average RMB 1K cheaper than tier 3 brethren</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Beijing Health Bureau released average hospitalized fee and hospital s......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 03 Nov 2009 15:58:53  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Beike makes fat investment- gains access to adipose-derived stem cell technology</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/Hf5pqTQxur8/cpbsubscribe.asp</link><description>Shenzhen Beike Biotechnology has entered an investment agreement with ......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/Hf5pqTQxur8" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 03 Nov 2009 15:23:50  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbsubscribe.asp</feedburner:origLink></item><item><title>Billion dollar baby- Novartis commits USD 1b for Shanghai R&amp;D center  --Free access</title><link>http://feedproxy.google.com/~r/cpbheadline/~3/ra1096wyrqs/cpbheadlinefree.asp</link><description>Novartis signed a memorandum of strategic cooperation with the Shangha......&lt;img src="http://feeds.feedburner.com/~r/cpbheadline/~4/ra1096wyrqs" height="1" width="1"/&gt;</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 03 Nov 2009 15:22:35  +0800</pubDate><feedburner:origLink>http://www.gbipharma.com/cpbheadlinefree.asp?newsid=2010729</feedburner:origLink></item></channel></rss>
